CALL - SPRINTER OPEN END - STRYKER CORP. Stock

Certificat

DE000VM55FV5

Delayed Deutsche Boerse AG 02:04:10 2024-07-16 pm EDT
14.99 EUR +1.70% Intraday chart for CALL - SPRINTER OPEN END - STRYKER CORP.
Current month-6.25%
1 month-7.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 14.99 +1.70%
24-07-15 14.74 -6.23%
24-07-12 15.72 +1.16%
24-07-11 15.54 +0.65%
24-07-10 15.44 +0.26%

Delayed Quote Deutsche Boerse AG

Last update July 16, 2024 at 02:04 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM55FV
ISINDE000VM55FV5
Date issued 2023-11-29
Strike 170.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 12.43
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 17.97
Lowest since issue 11.52
Spread 0.34
Spread %2.23%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
333.4 USD
Average target price
372.7 USD
Spread / Average Target
+11.79%
Consensus